Accelerating drug target inhibitor discovery with a deep generative foundation model
Science Advances · 23.06.2023 · 9 (25)
DOI: 10.1126/sciadv.adg7865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 23.06.2023. Verfasst von Vijil Chenthamarakshan und 19 weiteren Autor:innen. Beteiligte Einrichtung: IBM Research, Thomas J. Watson Research Center, Yorktown Heights, New York, NY, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, COVID-19. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Inhibitor discovery for emerging drug-target proteins is challenging, especially when target structure or active molecules are unknown. Here, we experimentally validate the broad utility of a deep generative framework trained at-scale on protein sequences, small molecules, and their mutual interactions—unbiased toward any specific target. We performed a protein sequence-conditioned sampling on the generative foundation model to design small-molecule inhibitors for two dissimilar targets: the spike protein receptor-binding domain (RBD) and the main protease from SARS-CoV-2. Despite using only the target sequence information during the model inference, micromolar-level inhibition was observed in vitro for two candidates out of four synthesized for each target. The most potent spike RBD inhibitor exhibited activity against several variants in live virus neutralization assays. These results establish that a single, broadly deployable generative foundation model for accelerated inhibitor discovery is effective and efficient, even in the absence of target structure or binder information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- IBM Research, Thomas J. Watson Research Center, Yorktown Heights, New York, NY, USA.
- Diamond Light Source Ltd., Harwell Science and Innovation Campus, OX11 0DE Didcot, UK.
- Research Complex at Harwell, Harwell Science and Innovation Campus, OX11 0FA Didcot, UK.
- Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, 12 Mansfield Road, OX1 3TA Oxford, UK.
- Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
- Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
ORCID-Profile: Vijil Chenthamarakshan, Samuel C Hoffman, C David Owen, Petra Lukacik, Claire Strain-Damerell, Daren Fearon, Christopher J Schofield, Helen M E Duyvesteyn, Loic Carrique, Thomas S Walter, Gavin R Screaton, Jason Crain, Martin A Walsh, David I Stuart, Payel Das
Förderung
- Medical Research Council
Zitieren
APA
Chenthamarakshan, V., Hoffman, S. C., Owen, C. D., Lukacik, P., Strain-Damerell, C., Fearon, D., Malla, T. R., Tumber, A., Schofield, C. J., Duyvesteyn, H. M. E., Dejnirattisai, W., Carrique, L., Walter, T. S., Screaton, G. R., Matviiuk, T., Mojsilovic, A., Crain, J., Walsh, M. A., Stuart, D. I., & Das, P. (2023). Accelerating drug target inhibitor discovery with a deep generative foundation model. Science Advances, 9(25). https://doi.org/10.1126/sciadv.adg7865
Vancouver
Chenthamarakshan V, Hoffman SC, Owen CD, Lukacik P, Strain-Damerell C, Fearon D, et al. Accelerating drug target inhibitor discovery with a deep generative foundation model. Science Advances. 2023;9(25). doi:10.1126/sciadv.adg7865
BibTeX
@article{Chenthamarakshan2023,
author = {Chenthamarakshan, Vijil and Hoffman, Samuel C and Owen, C David and Lukacik, Petra and Strain-Damerell, Claire and Fearon, Daren and Malla, Tika R and Tumber, Anthony and Schofield, Christopher J and Duyvesteyn, Helen M E and Dejnirattisai, Wanwisa and Carrique, Loic and Walter, Thomas S and Screaton, Gavin R and Matviiuk, Tetiana and Mojsilovic, Aleksandra and Crain, Jason and Walsh, Martin A and Stuart, David I and Das, Payel},
title = {Accelerating drug target inhibitor discovery with a deep generative foundation model},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {25},
doi = {10.1126/sciadv.adg7865}
}
EUVIMED